Clinical Trial Update: Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating topical AS101 for female androgenetic alopecia in menopausal women. Sponsor: Rabin Medical Center; trial status is UNKN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• AS101

Snippet

Sponsor: Rabin Medical Center | Conditions: Alopecia | Phase 2 | Status: UNKNOWN